Extracellular vesicles — new tool for joint repair and regeneration

Cell-derived extracellular vesicles (EVs), present in synovial fluid and cartilage extracellular matrix (ECM), are involved in joint development and in the regulation of joint homeostasis. Although the exact function of EVs in these processes remains incompletely defined, the knowledge already acquired in this field suggests a role for these EVs as biomarkers of joint disease, and as a new tool to restore joint homeostasis and enhance articular tissue regeneration. In addition to direct injection of therapeutic EVs into the target site, surface coating of scaffolds and embedding of EVs in hydrogels might also lead to novel therapeutic possibilities. Based on the existing literature of EVs in synovial fluid and articular tissues, and investigation of the molecular factors (including microRNAs) active in joint homeostasis (or during its disturbance), we postulate novel perspectives for the implementation of EVs as a regenerative medicine approach in joint repair.

[1]  A. Hill,et al.  Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells , 2012, Nucleic acids research.

[2]  Arnold I Caplan,et al.  The MSC: an injury drugstore. , 2011, Cell stem cell.

[3]  H. Anderson.  Matrix vesicles and calcification , 2003, Current rheumatology reports.

[4]  J. Simon,et al.  Mesenchymal stem cells in cartilage regeneration. , 2014, Current stem cell research & therapy.

[5]  Daniel A. Grande,et al.  The current state of scaffolds for musculoskeletal regenerative applications , 2015, Nature Reviews Rheumatology.

[6]  D. Pisetsky,et al.  The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Altevogt,et al.  Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling* , 2013, The Journal of Biological Chemistry.

[8]  Lesley Cheng,et al.  Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood , 2014, Journal of extracellular vesicles.

[9]  Liling Xu,et al.  Toll-Like Receptors Expressed by Synovial Fibroblasts Perpetuate Th1 and Th17 Cell Responses in Rheumatoid Arthritis , 2014, PloS one.

[10]  J. Malda,et al.  Biofabrication of multi-material anatomically shaped tissue constructs , 2013, Biofabrication.

[11]  M. Record,et al.  Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. , 2014, Biochimica et biophysica acta.

[12]  A. Falus,et al.  Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts , 2009, Arthritis research & therapy.

[13]  A. Falus,et al.  Emerging role of extracellular vesicles in inflammatory diseases , 2014, Nature Reviews Rheumatology.

[14]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[15]  Lesley Cheng,et al.  Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. , 2014, Kidney International.

[16]  M. Goldring,et al.  Cartilage homeostasis in health and rheumatic diseases , 2009, Arthritis research & therapy.

[17]  Richard W. Farndale,et al.  Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production , 2010, Science.

[18]  Yoshio Kato,et al.  MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. , 2009, Arthritis and rheumatism.

[19]  Roopashree Subbaiah,et al.  The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes , 2012, EMBO molecular medicine.

[20]  Imre Mäger,et al.  Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting , 2015, Journal of extracellular vesicles.

[21]  S. Schibeci,et al.  Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis. , 2014, Clinical immunology.

[22]  P. Ghosh,et al.  The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment , 2004, Rheumatology International.

[23]  D. Pisetsky,et al.  Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. , 2007, Arthritis and rheumatism.

[24]  J. Gottenberg,et al.  Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes , 2009, Arthritis research & therapy.

[25]  M. Gelb,et al.  Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA , 2015, Proceedings of the National Academy of Sciences.

[26]  Luigi Biancone,et al.  Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.

[27]  W. Grizzle,et al.  A Membrane Form of TNF-α Presented by Exosomes Delays T Cell Activation-Induced Cell Death1 , 2006, The Journal of Immunology.

[28]  Anikó Szalai,et al.  Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. , 2011, Blood.

[29]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[30]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[31]  A. Willms,et al.  Extracellular Vesicle Profiling and Their Use as Potential Disease Specific Biomarker , 2014, Front. Immunol..

[32]  P. Altevogt,et al.  Extracellular Vesicle-Mediated Transfer of Genetic Information between the Hematopoietic System and the Brain in Response to Inflammation , 2014, Journal of Neuroimmunology.

[33]  Andrew F. Hill,et al.  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.

[34]  N. Baldini,et al.  Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy , 2012, Front. Physio..

[35]  Alessandro Busca,et al.  Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.

[36]  Daniel A Grande,et al.  Articular Cartilage Repair , 2013, Cartilage.

[37]  M. Wauben,et al.  Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis , 2004, Annals of the rheumatic diseases.

[38]  A. Falus,et al.  Improved Flow Cytometric Assessment Reveals Distinct Microvesicle (Cell-Derived Microparticle) Signatures in Joint Diseases , 2012, PloS one.

[39]  Peixin Yang,et al.  Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer , 2015, Breast Cancer Research and Treatment.

[40]  A. Reddi,et al.  MicroRNAs in chondrogenesis, articular cartilage, and osteoarthritis: implications for tissue engineering. , 2012, Tissue engineering. Part B, Reviews.

[41]  R. Terkeltaub,et al.  Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. , 2010, Arthritis and rheumatism.

[42]  D. Markovitz,et al.  The DEK Nuclear Autoantigen Is a Secreted Chemotactic Factor , 2006, Molecular and Cellular Biology.

[43]  S. Mathivanan,et al.  Exosomes in bodily fluids are a highly stable resource of disease biomarkers , 2015, Proteomics. Clinical applications.

[44]  Anne-Sofie Lagerstedt,et al.  The Dog as an Animal Model for Intervertebral Disc Degeneration? , 2012, Spine.

[45]  R. Schiffelers,et al.  Extracellular Vesicles: Potential Roles in Regenerative Medicine , 2014, Front. Immunol..

[46]  Shinobu Ueda,et al.  Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[47]  J. Zwerina,et al.  Microparticles stimulate angiogenesis by inducing ELR+ CXC-chemokines in synovial fibroblasts , 2010, Journal of cellular and molecular medicine.

[48]  Wim E Hennink,et al.  25th Anniversary Article: Engineering Hydrogels for Biofabrication , 2013, Advanced materials.

[49]  M. Ochi,et al.  The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. , 2011, Arthritis and rheumatism.

[50]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[51]  S. Miyaki,et al.  Expression of MicroRNA-146a in osteoarthritis cartilage. , 2009, Arthritis and rheumatism.

[52]  A. Samad,et al.  Liposomal drug delivery systems: an update review. , 2007, Current drug delivery.

[53]  Xing Zhao,et al.  Concise Review: Unraveling Stem Cell Cocultures in Regenerative Medicine: Which Cell Interactions Steer Cartilage Regeneration and How? , 2014, Stem cells translational medicine.

[54]  M. Cho,et al.  The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. , 2006, Arthritis and rheumatism.

[55]  A. Falus,et al.  The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis. , 2013, Immunology letters.

[56]  Jacco van Rheenen,et al.  In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior , 2015, Cell.

[57]  D. Saris,et al.  Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes. , 2014, Osteoarthritis and cartilage.

[58]  M. Lotz,et al.  Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes , 2014, Arthritis Research & Therapy.

[59]  P. Tak,et al.  Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes , 2005, Arthritis research & therapy.

[60]  P. R. Weeren,et al.  Comparative study of depth-dependent characteristics of equine and human osteochondral tissue from the medial and lateral femoral condyles. , 2012, Osteoarthritis and cartilage.

[61]  Y. Konttinen,et al.  Toll-like receptors in human chondrocytes and osteoarthritic cartilage , 2013, Acta orthopaedica.

[62]  H. Nagase,et al.  Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity , 2012, Matrix biology : journal of the International Society for Matrix Biology.

[63]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[64]  H. Anderson,et al.  Matrix vesicles are carriers of bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF), and noncollagenous matrix proteins , 2008, Journal of Bone and Mineral Metabolism.

[65]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[66]  Dong Wei,et al.  Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer , 2008, Molecular Therapy.

[67]  L. Sarda,et al.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells , 1995, Cell.

[68]  F. Breedveld,et al.  Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. , 2002, Arthritis and rheumatism.

[69]  A. Augello,et al.  Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases. , 2011, Arthritis and rheumatism.

[70]  G. Herrero-Beaumont,et al.  TLR4 signalling in osteoarthritis—finding targets for candidate DMOADs , 2015, Nature Reviews Rheumatology.

[71]  G R Burmester,et al.  Association of citrullinated proteins with synovial exosomes. , 2006, Arthritis and rheumatism.

[72]  M. Zöller,et al.  Host matrix modulation by tumor exosomes promotes motility and invasiveness. , 2013, Neoplasia.

[73]  M. Wood,et al.  Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles. , 2015, Human gene therapy.

[74]  J. Jurvelin,et al.  Preclinical Studies for Cartilage Repair: Recommendations from the International Cartilage Repair Society , 2011 .

[75]  H. Anderson.  VESICLES ASSOCIATED WITH CALCIFICATION IN THE MATRIX OF EPIPHYSEAL CARTILAGE , 1969, The Journal of cell biology.

[76]  Simon C Watkins,et al.  Exosomes Derived from IL-10-Treated Dendritic Cells Can Suppress Inflammation and Collagen-Induced Arthritis 1 , 2005, The Journal of Immunology.

[77]  M. Epple,et al.  MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease , 2014, Leukemia.

[78]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[79]  H. Schumacher,et al.  Platelets can enhance vascular permeability. , 2012, Blood.